|1|Prediction of adverse events during Intensive Induction chemotherapy for acute myeloid leukemia or high-grade myelodysplastic syndromes. (24382796)
Buckley S.A.... Walter R.B.
|2|Differentiation therapy for the treatment of t(8;21) acute myeloid leukemia using histone deacetylase inhibitors. (24415537)
Bots M.... Johnstone R.W.
|3|Core-binding factor acute myeloid leukemia: can we improve on HiDAC consolidation? (24319183)
Paschka P.... DAPhner K.
|4|Management options for refractory chronic myeloid leukemia: considerations for the elderly. (23615798)
Breccia M.... Alimena G.
|5|Down-regulation of miR-181c in imatinib-resistant chronic myeloid leukemia. (23866735)
Mosakhani N.... Knuutila S.
|6|Notch2 inhibits proliferation of chronic myeloid leukemia cells. (23599800)
Yang Z.... Chen J.
|7|SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias. (23443343)
Damm F.... Solary E.
|8|Nonhematopoietic cells represent a more rational target of inA vivo hedgehog signaling affecting normal or acute myeloid leukemia progenitors. (23747997)
Boyd A.L.... Bhatia M.
|9|Activity of the hypoxia-activated prodrug, TH-302, in preclinical human acute myeloid leukemia models. (24088735)
Portwood S.... Wang E.S.
|10|Gingival enlargement as an early diagnostic indicator in therapy-related acute myeloid leukemia: A rare case report and review of literature. (23869136)
Gowda T.M.... Mehta D.S.
|11|The PERK-eIF2I+ phosphorylation arm is a pro-survival pathway of BCR-ABL signaling and confers resistance to imatinib treatment in chronic myeloid leukemia cells. (23095523)
Kusio-Kobialka M.... Piwocka K.
|12|The pro-metastasis tyrosine phosphatase, PRL-3 (PTP4A3), is a novel mediator of oncogenic function of BCR-ABL in human chronic myeloid leukemia. (22995644)
Zhou J.... Chng W.J.
|13|Chronic graft versus host disease with small bowel obstruction after unrelated hematopoietic stem cell transplantation in a patient with acute myeloid leukemia. (22783362)
Yoon J.Y.... Ahn H.S.
|14|MicroRNA-29a and microRNA-142-3p are regulators of myeloid differentiation and acute myeloid leukemia. (22493297)
Wang X.S.... Zhang J.W.
|15|Diabetes insipidus as an atypical presentation of acute myeloid leukemia. (22424594)
Portela M.... Dalama B.
|16|Relationships between the gene polymorphisms of drug metabolizing enzymes and the outcome of the first induction chemotherapy in patients with de novo acute myeloid leukemia]. (21518482)
Wang N.... Han M.Z.
|17|Detection of nucleophosmin and FMS-like tyrosine kinase-3 gene mutations in acute myeloid leukemia. (21245599)
Pazhakh V.... Atashrazm F.
|18|The clinical characteristics of CD7+ CD56+ acute myeloid leukemias other than M0. (20111912)
Suzuki R.... Naoe T.
|19|Minimal residual disease diagnostics in patients with acute myeloid leukemia in the post-transplant period: comparison of peripheral blood and bone marrow analysis. (20849383)
Stahl T.... Bacher U.
|20|Hematopoietic stem cell transplantation for core binding factor acute myeloid leukemia: t(8;21) and inv(16) represent different clinical outcomes. (19126873)
Kuwatsuka Y.... Kodera Y.
|21|Loss of RAF kinase inhibitor protein is a somatic event in the pathogenesis of therapy-related acute myeloid leukemias with C-RAF germline mutations. (19357705)
Zebisch A.... Sill H.
|22|A clinical trial for homoharringtonine and low-dose cytosine arabinoside combined with G-CSF or GM-CSF to treat the relapsed or refractory acute myeloid leukemia (AML), geriatric AML and advanced myelodysplastic syndromes]. (19292062)
Xu J.... He C.
|23|Trisomy of chromosome 8 in Ph-negative cells of the bone marrow in patients with chronic myeloid leukemia treated with inhibitors of BCR-ABL tyrosine kinases]. (19708570)
Turkina A.G.... Khoroshko N.D.
|24|Cytoplasmic mutated nucleophosmin is stable in primary leukemic cells and in a xenotransplant model of NPMc+ acute myeloid leukemia in SCID mice. (18367491)
Falini B.... Schnittger S.
|25|Evaluation of beta-catenin activating mutations in chronic myeloid leukemia. (17977597)
Chomel J.C.... Turhan A.G.
|26|High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated. (18272813)
Lugthart S.... Delwel R.
|27|Myeloid leukemias express a broad spectrum of VEGF receptors including neuropilin-1 (NRP-1) and NRP-2. (17917967)
Vales A.... Valent P.
|28|Epigenetic regulation of brain expressed X-linked-2, a marker for acute myeloid leukemia with mixed lineage leukemia rearrangements. (17251904)
Fischer C.... Quentmeier H.
|29|Targeting receptor tyrosine kinase signaling in acute myeloid leukemia. (17658267)
Doepfner K.T.... Arcaro A.
|30|The polycomb group BMI1 gene is a molecular marker for predicting prognosis of chronic myeloid leukemia. (17360938)
Mohty M.... Melo J.V.
|31|Constitutive c-jun N-terminal kinase activity in acute myeloid leukemia derives from Flt3 and affects survival and proliferation. (16982329)
Hartman A.D.... Boswell H.S.
|32|Assessment of bone marrow mesenchymal stem cell biological characteristics and support hemotopoiesis function in patients with chronic myeloid leukemia. (16448696)
Zhao Z.... Zou P.
|33|Activation of Raf1 and the ERK pathway in response to l-ascorbic acid in acute myeloid leukemia cells. (15451031)
Park S.... Lee J.H.
|34|Evidence for a positive role of SHIP in the BCR-ABL-mediated transformation of primitive murine hematopoietic cells and in human chronic myeloid leukemia. (12829595)
Jiang X.... Eaves C.
|35|Cadherin-13, a mediator of calcium-dependent cell-cell adhesion, is silenced by methylation in chronic myeloid leukemia and correlates with pretreatment risk profile and cytogenetic response to interferon alfa. (12697869)
Roman-Gomez J.... Torres A.
|36|SU5416, a small molecule tyrosine kinase receptor inhibitor, has biologic activity in patients with refractory acute myeloid leukemia or myelodysplastic syndromes. (12649163)
Giles F.J.... Karp J.E.
|37|Clinical and biological implications of partial tandem duplication of the MLL gene in acute myeloid leukemia without chromosomal abnormalities at 11q23. (11840285)
Shiah H.S.... Tien H.F.
|38|Polymorphism analysis of CYP3A5 in myeloid leukemia. (11836601)
Liu T.C.... Chang J.G.
|39|Peripheral blood leucocytes ornithine decarboxylase activity in chronic myeloid leukemia patients: prognostic and therapeutic implications. (11839377)
Tripathi A.K.... Tekwani B.L.
|40|Transformation of myeloid leukemia cells to cytokine independence by Bcr-Abl is suppressed by kinase-defective Hck. (10849448)
Lionberger J.M.... Smithgall T.E.
|41|Internal tandem duplication of the FLT3 gene and clinical evaluation in childhood acute myeloid leukemia. The Children's Cancer and Leukemia Study Group, Japan. (10049058)
Iwai T.... Fujimoto T.
|42|Mutant RAS selectively promotes sensitivity of myeloid leukemia cells to apoptosis by a protein kinase C-dependent process. (9581849)
Gallagher A.P.... Darley R.L.
|43|Value of molecular monitoring during the treatment of chronic myeloid leukemia: a Cancer and Leukemia Group B study. (8996121)
Stock W.... Bloomfield C.D.
|44|Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemia. (8630412)
List A.F.... Dalton W.S.
|45|Relapsing acute myeloid leukemia manifesting as hypopyon uveitis. (7872398)
Ayliffe W.... Legmann A.
|46|Acute myeloid leukemia M4 with bone marrow eosinophilia (M4Eo) and inv(16)(p13q22) exhibits a specific immunophenotype with CD2 expression. (8098967)
Adriaansen H.J.... van Dongen J.J.
|47|Correlation between serum level of soluble L-selectin and leukocyte count in chronic myeloid and lymphocytic leukemia and during bone marrow transplantation. (7690331)
Zetterberg E.... Richter J.
|48|Flow cytometric characterization of acute myeloid leukemia. Part II. Phenotypic heterogeneity at diagnosis. (1540262)
Terstappen L.W.... WAPrmann B.
|49|Human recombinant stem cell factor stimulates in vitro proliferation of acute myeloid leukemia cells and expands the clonogenic cell pool. (1378162)
Carlesso N.... Ferrero D.
|50|In vitro differentiation of leukemic cells to eosinophils in the presence of interleukin-5 in two cases of acute myeloid leukemia with the translocation (8;21)(q22;q22). (1688504)
Ema H.... Miura Y.